Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027121 (
myositis
)
4,538
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
B7 family members regulate T cell activation and tolerance. Although butyrophilin proteins share sequence homology with the B7 molecules, it is unclear whether they have any function in immune responses. In the present study, we characterize an MHC class II gene-linked butyrophilin family member,
butyrophilin-like 2
(
BTNL2
), the mutation of which has been recently associated with the inflammatory autoimmune diseases sarcoidosis and
myositis
. Mouse
BTNL2
is a type I transmembrane protein with two pairs of Ig-like domains separated by a heptad peptide sequence.
BTNL2
mRNA is highly expressed in lymphoid tissues as well as in intestine. To characterize the function of
BTNL2
, we produced a
BTNL2
-Ig fusion protein. It recognized a putative receptor whose expression on B and T cells was significantly enhanced after activation.
BTNL2
-Ig inhibited T cell proliferation and TCR activation of NFAT, NF-kappaB, and AP-1 signaling pathways.
BTNL2
is thus the first member of the butyrophilin family that regulates T cell activation, which has implications in immune diseases and immunotherapy.
...
PMID:BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. 1675 79